Best Sleep Aid for Patients with Tinnitus
For patients with tinnitus experiencing sleep difficulties, cognitive behavioral therapy for insomnia (CBT-I) is the first-line treatment, NOT pharmacological sleep aids. 1
Primary Recommendation: CBT-I First
The American College of Physicians strongly recommends CBT-I as initial treatment for chronic insomnia in all adults, including those with tinnitus 1. This approach is particularly appropriate for tinnitus patients because:
- CBT-I addresses both insomnia and tinnitus-related distress without medication side effects
- The noninvasive nature means adverse effects are likely to be mild 1
- Tinnitus guidelines emphasize cognitive behavioral therapy (CBT) for persistent, bothersome tinnitus 2, and CBT-I shares similar therapeutic mechanisms
CBT-I Components Include:
- Stimulus control (leave bed if not asleep within ~20 minutes)
- Sleep restriction therapy
- Relaxation training (progressive muscle relaxation)
- Cognitive therapy to address dysfunctional beliefs about sleep
- Sleep hygiene education 3
If Pharmacotherapy Is Necessary
When CBT-I fails or is unavailable, short/intermediate-acting benzodiazepine receptor agonists (BzRAs) or ramelteon are recommended 3, with important caveats for tinnitus patients:
First-Line Pharmacologic Options:
- Zaleplon or ramelteon (very short half-life) - for sleep onset difficulty with minimal residual sedation
- Eszopiclone or temazepam (longer half-life) - for sleep maintenance issues, though more likely to cause morning sedation 3
Critical Consideration for Tinnitus Patients:
Avoid triazolam - associated with rebound anxiety and not considered first-line 3. This is particularly important since tinnitus patients often have coexisting anxiety that requires prompt identification 2.
Ramelteon may be preferred for patients with substance use history (not DEA-scheduled) and those with sleep initiation difficulty 3.
What NOT to Use
Do not routinely recommend antidepressants, anticonvulsants, or anxiolytics for treating tinnitus 2. While these are commonly prescribed off-label for insomnia (particularly trazodone) 4, the tinnitus guidelines explicitly recommend against their routine use for tinnitus management due to:
- Insufficient evidence of efficacy
- Significant potential side effects
- Some medications (especially antidepressants) may actually worsen tinnitus 2
Do not recommend dietary supplements (melatonin, valerian, Ginkgo biloba, zinc) - insufficient evidence for efficacy in both insomnia 3 and tinnitus 2, 4
Clinical Algorithm
First: Assess tinnitus severity and psychiatric comorbidity
Initiate CBT-I as primary treatment for insomnia 1
- Can be delivered individually, in groups, via telephone/web, or self-help 1
- Addresses both sleep and tinnitus-related cognitive distortions
If pharmacotherapy needed:
Concurrent tinnitus management:
Important Pitfalls to Avoid
- Don't prescribe sedating antidepressants (trazodone, doxepin) as first-line despite their common off-label use - no efficacy studies for insomnia in tinnitus patients and may worsen tinnitus 2, 4
- Don't ignore psychiatric screening - tinnitus with severe anxiety/depression requires prompt intervention 2
- Don't use long-term benzodiazepines - FDA recommends short-term use; serious adverse effects include dementia and fractures in observational studies 1
- Avoid polypharmacy - many tinnitus patients are already on multiple medications; adding hypnotics increases interaction risk 1
The evidence strongly favors a behavioral approach first, with judicious short-term use of specific hypnotics only when necessary, while actively managing the underlying tinnitus through evidence-based interventions.